BCRX - BioCryst Corp Sales Growth YoY (Last Twelve Months)
The YoY revenue growth rate for the rolling 12-month period is based on global alliances with medical centers to implement innovations. Scaling the distribution of oral medications optimizes operating expenses, while the 59.90 metric determines this level. This trend relies on the status of BioCryst (BCRX) as an authoritative developer of therapies for rare immune pathologies, creating life-saving drugs.
%20%5Blogo%5D%20BCRX&width=1200&height=400&colorIndex=0&v=mwhdatcg.m7-7dqbc3k&start=20220704&end=20261115&filename=GURU_Markets_-_BCRX_-_BioCryst_-_Sales-Growth-YoY-TTM "BioCryst Pharmaceuticals - BCRX Annual Revenue Growth (Last Twelve Months) (period 02/11/2024 - 11/15/2026) | 👁️GURU.Markets👁️")
Summary analytical data breakdowns for BioCryst Pharmaceuticals (BCRX)
- market value and analyst target forecast:
- market capitalization statistics:
- business book valuation details:
- business debt structure and liquidity details:
Total Debt to Equity Ratio BioCryst|BCRX - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital BioCryst Pharmaceuticals Inc|BCRX - Company Total Debt|Debts to Book Value BioCryst Pharmaceuticals, Inc.|BCRX - Company Long-Term Debt|Short-Term Debt Volume BioCryst|Intermediate Liquidity Ratio biocryst.com
- company profitability and valuation multiples indicators:
BCRX - Net Profit|Expected Profit BioCryst|BCRX - P/E Multiple|Projected Price to Earnings biocryst.com|BCRX - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation BioCryst Pharmaceuticals Inc|BCRX - Operating profit before deduction of amortization|Earnings per share for the last 12 months BioCryst|BCRX - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months biocryst.com|BCRX - Earnings growth in current year|Expected earnings per share trend next year BioCryst
- sales and revenue data:
Fundamental company valuation:BioCryst
The success of BioCryst (BCRX) is based on the commercialization of Orladeyo, which transformed the treatment of hereditary angioedema by replacing injections with an oral form. The trailing twelve-month (TTM) sales dynamics compared to the previous year reflect the expansion rate of this product by measuring the percentage change in TTM revenue; the steady growth of this indicator confirms the scaling of market share and the fundamental resilience of the company's business model.
Competitors of BioCryst (BCRX)
Argenx (ARGX) - Trailing Twelve Months Revenue Growth|BioNTech SE - Sales Growth YoY (TTM)|ABVX - Sales Growth YoY (TTM)|ADMA: Sales Growth YoY (TTM)|Protagonist Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Immunovant Therapeutics|Sales Growth YoY (Last 12 Months) KNSA (Kiniksa Pharmaceuticals Ltd)|Sales Growth YoY (TTM) GRFS|ADPT: Trailing Twelve Months Sales Growth|Sales Growth YoY (TTM) CLDX (Celldex)|AUPH: Sales Growth YoY (Last 12 Months)|VERA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) DNTH (Dianthus Therapeutics)|Pharvaris N.V. (PHVS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth AbCellera Biologics (ABCL)|TRML (Tourmaline Bio Inc) - Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) PGEN (Intrexon)|Revenue Growth YoY (Last 12 Months) PHAR (Pharming)|NKTR (Nektar) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) UPB (upstreambio.com)|ZBIO (Zenas Biopharma Inc) - Trailing Twelve Months Sales Growth|IMNM - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Gossamer Bio Inc GOSS|KALV: Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Septerna Pharma|PVLA (Pieris Corp) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) SVRA|Sales Growth YoY (TTM) RIGL|Revenue Growth YoY (Last 12 Months) AnaptysBio Corp ANAB|Astria Therapeutics Inc - Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) enGene Holdings Inc. (ENGN)|RAPT Therapeutics Inc. - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Aerovate Therapeutics, Inc.|ACRS (Aclaris Therapeutics) - Revenue Growth YoY (Last 12 Months)|KYTX: Revenue Change YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) Tiziana Life Sciences|Cabaletta Bio, Inc (CABA) - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) VTYX (Ventyx Biosciences)|Annual Revenue Growth (Last Twelve Months) theratech.com|Sales Growth YoY (TTM) AVTX (Avalo Therapeutics, Inc.)|Sales Growth YoY (TTM) Eledon Pharmaceuticals Inc. ELDN|AGEN: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) CLYM (Climb Bio, Inc)|ZURA: Sales Growth YoY (TTM)|aTyr Pharma, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Adagene Inc.|IMA: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) STTK|Revenue Growth YoY (Last 12 Months) Equillium Bio EQ|Sales Growth YoY (Last Twelve Months) Connect Biopharma CNTB|IMUX - Revenue Growth YoY (Last 12 Months)|ATRA - Sales Growth YoY (Last Twelve Months)|InflaRx NV (IFRX) - Revenue Growth YoY (Last 12 Months)|XFOR (X4 Pharmaceuticals Inc.) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Adicet Bio Inc. (ACET)|Sales Growth YoY (Last Twelve Months) celularity.com|Revenue Growth YoY (Last 12 Months) inmunebio.com (INMB)|Sales Growth YoY (Last Twelve Months) Barinthus Biotherapeutics PLC (BRNS)|Annual Revenue Growth (Last Twelve Months) Kezar Life Sciences Inc.|SAB Biotherapeutics, Inc - Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) Akari Therapeutics, Plc (AKTX)|ENLV: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QTTB (q32bio.com)|GeoVax Labs Inc (GOVX) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) Edesa|Sales Growth YoY (Last Twelve Months) iBio, Inc.|Revenue Growth YoY (Last 12 Months) carismatx.com (CARM)|Sales Growth YoY (TTM) XTLB|Revenue Growth YoY (Last 12 Months) Bolt Bio BOLT|Sales Growth YoY (TTM) HCWB (HCW Biologics)|APVO: Sales Growth YoY (Last 12 Months)|AIM - Sales Growth YoY (Last Twelve Months)|ADTX - Sales Growth YoY (TTM)|GRI Bio (GRI) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) XORTX Therapeutics|Sales Growth YoY (Last Twelve Months) Vyome Therapeutics|Sales Growth YoY (Last 12 Months) REVB (Revelation Biosciences, Inc.)|Sales Growth YoY (TTM) INDP|Revenue Growth YoY (Last 12 Months) Scinai Immunotherapeutics SCNI|Sales Growth YoY (TTM) CALI (CalciMedica)|AFMD - Revenue Growth YoY (Last 12 Months)|ALLK: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) HOOKIPA Pharma HOOK|IGMS: Sales Growth YoY (TTM)|ITOS: Revenue Change YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) Ocean Biomedical|tcbiopharm.com - Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Third Harmonic Bio, Inc. (THRD)
